Characteristics and properties of the selected peptide sequences – in silico results.
| Peptide IDa | Immunogenicityb (%) | Conservationc | MW (Da) | Ip | CPd | CNe | AI |
|---|---|---|---|---|---|---|---|
| P1 | 99.99 | 100 | 2055.27 | 4.68 | 2 | 3 | 70.56 |
| P2 | 95.29 | 83.33 | 2288.57 | 8.44 | 2 | 3 | 37.78 |
| P3 | 92.94 | 77.78 | 2087.28 | 8.76 | 2 | 1 | 43.33 |
| J4 | 86.17 | 94.44 | 2090.28 | 8.15 | 2 | 1 | 81.11 |
| J5 | 98.82 | 77.78 | 1980.22 | 7.94 | 1 | 0 | 65.00 |
a
Peptide sequences under Brazilian patent deposit pending.
b
Percentage of immunogenicity when compared with the highest scoring peptide in the spike protein, based on the combination of the B-cell epitope predictors.
c
Number of residues that were identical in at least 90% of the evaluated isolates.
d
Total number of positively charged peptides.
e
Total number of negatively charged peptides.